SG Americas Securities
MIRM icon

SG Americas Securities’s Mirum Pharmaceuticals MIRM Stock Holding History

SG Americas Securities’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Buy
30,769
+26,054
+553% +$2.62M ﹤0.01% 1235
2026
Q1 		$436K Sell
4,715
-13,995
-75% -$1.32M ﹤0.01% 2255
2025
Q4 		$1.48M Buy
+18,710
New +$1.34M ﹤0.01% 1727
2025
Q3 		– Sell
-2,126
Closed -$108K – 3490
2025
Q2 		$108K Sell
2,126
-17,056
-89% -$759K ﹤0.01% 2607
2025
Q1 		$864K Buy
19,182
+12,204
+175% +$575K ﹤0.01% 1293
2024
Q4 		$289K Sell
6,978
-4,275
-38% -$178K ﹤0.01% 1823
2024
Q3 		$439K Buy
+11,253
New +$449K ﹤0.01% 1803
2024
Q1 		– Sell
-12,405
Closed -$366K – 3249
2023
Q4 		$366K Sell
12,405
-13,342
-52% -$404K ﹤0.01% 1672
2023
Q3 		$814K Buy
25,747
+9,093
+55% +$249K 0.01% 1441
2023
Q2 		$431K Buy
16,654
+7,941
+91% +$211K ﹤0.01% 1467
2023
Q1 		$209K Buy
+8,713
New +$199K ﹤0.01% 2389

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SG Americas Securities's MIRM Position: Q2 2026 in Review

SG Americas Securities increased its Mirum Pharmaceuticals (MIRM) stake by 553% in Q2 2026, buying an estimated $2.62M and bringing the position to 30,769 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

SG Americas Securities first reported a position in MIRM in Q1 2023 and has held it in 11 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • SG Americas Securities held 30,769 shares of Mirum Pharmaceuticals worth $3.6M as of Q2 2026.
  • SG Americas Securities bought 26,054 Mirum Pharmaceuticals shares in Q2 2026, an estimated $2.62M.
  • Mirum Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1235 holding.
  • SG Americas Securities first reported a position in Mirum Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.